Ovarian hormones and uterine growth

1961 ◽  
Vol 82 (3) ◽  
pp. 712
Author(s):  
Robert E.L. Nesbitt
1969 ◽  
Vol 45 (1) ◽  
pp. 91-97 ◽  
Author(s):  
B. T. DONOVAN

SUMMARY Ovarian tissue was autografted to the spleen or kidney of spayed anoestrous or oestrous ferrets to see whether inactivation of ovarian hormones occurred in the liver and to examine the feedback action of gonadal hormones on gonadotrophin secretion. Although the grafts survived in both sites as did homografts made in anoestrous females, the secretion of gonadal hormones was sufficient to cause oestrus only in a minority of animals and there was little difference in the function of grafts made to the spleen or kidney. Vulval swelling and uterine growth were caused by pellets of oestradiol inserted into the spleen so that it appears that this steroid can pass through the liver without loss of oestrogenic activity. It is concluded that little inactivation of gonadal steroids by the liver of the ferret takes place.


1966 ◽  
Vol 34 (4) ◽  
pp. 469-478 ◽  
Author(s):  
B. T. DONOVAN ◽  
MARY C. O'KEEFFE

SUMMARY (1) The structure and function of ovarian autotransplants made to the spleen and kidney were compared in order to measure the ability of the liver to inactivate ovarian hormones at different ages in the rat. (2) In the immature rat the data from the uterine weights indicated that little or no hepatic inactivation of gonadal hormone occurred since grafts to the spleen or kidney were equally capable of maintaining normal uterine growth. (3) With increasing age, the liver appeared to develop the ability to inactivate ovarian hormones; this capacity was reflected by the difference in the uterine weights of animals bearing ovarian tissue in the kidney as opposed to those in the spleen. (4) The ability of the liver to metabolize ovarian hormones appeared to develop to a significant degree at about the time of puberty.


1979 ◽  
Vol 42 (04) ◽  
pp. 1332-1339 ◽  
Author(s):  
Hiroh Yamazaki ◽  
Takeshi Motomiya ◽  
Minoru Sonoda ◽  
Noboru Miyagawa

SummaryChanges in platelets in 48 patients with uterine myoma before and after hysterectomy with and without ovariectomy were examined. Bilateral ovariectomy in 25 cases (ovariec-tomized group) and unilateral or non-ovariectomy in 23 cases (control group) were performed at the hysterectomy. Platelet count and an appearance rate of secondary aggregation decreased at one day after and increased at one week after the operation, similarly in both the ovariectomized and the control group. The appearance rate of secondary aggregation was reflected in an intensity of aggregation at 5 min after the addition of reagent to PRP. At one month after the operation, the appearance rate of secondary aggregation induced by 3 μM ADP showed a statistically significant decrease in comparison with the preoperation value (P <0.05) and the enhancement of 5-min aggregation was still observed in the control group, while ceased in the ovariectomized group. The difference between the two groups was significant (P < 0.05). There was almost no change in the speed and intensity of primary and secondary aggregation during the observation period. No significant differences in collagen-induced aggregation were noted between the two groups. The results suggest that ovarian hormones, mainly estrogen, facilitate platelet activation which is mediated by the so-called secondary aggregation.


2014 ◽  
Vol 28 (6) ◽  
pp. 899-911 ◽  
Author(s):  
Sylvia C. Hewitt ◽  
Leping Li ◽  
Sara A. Grimm ◽  
Wipawee Winuthayanon ◽  
Katherine J. Hamilton ◽  
...  

Abstract Estrogen receptor α (ERα) interacts with DNA directly or indirectly via other transcription factors, referred to as “tethering.” Evidence for tethering is based on in vitro studies and a widely used “KIKO” mouse model containing mutations that prevent direct estrogen response element DNA- binding. KIKO mice are infertile, due in part to the inability of estradiol (E2) to induce uterine epithelial proliferation. To elucidate the molecular events that prevent KIKO uterine growth, regulation of the pro-proliferative E2 target gene Klf4 and of Klf15, a progesterone (P4) target gene that opposes the pro-proliferative activity of KLF4, was evaluated. Klf4 induction was impaired in KIKO uteri; however, Klf15 was induced by E2 rather than by P4. Whole uterine chromatin immunoprecipitation-sequencing revealed enrichment of KIKO ERα binding to hormone response elements (HREs) motifs. KIKO binding to HRE motifs was verified using reporter gene and DNA-binding assays. Because the KIKO ERα has HRE DNA-binding activity, we evaluated the “EAAE” ERα, which has more severe DNA-binding domain mutations, and demonstrated a lack of estrogen response element or HRE reporter gene induction or DNA-binding. The EAAE mouse has an ERα null–like phenotype, with impaired uterine growth and transcriptional activity. Our findings demonstrate that the KIKO mouse model, which has been used by numerous investigators, cannot be used to establish biological functions for ERα tethering, because KIKO ERα effectively stimulates transcription using HRE motifs. The EAAE-ERα DNA-binding domain mutant mouse demonstrates that ERα DNA-binding is crucial for biological and transcriptional processes in reproductive tissues and that ERα tethering may not contribute to estrogen responsiveness in vivo.


1960 ◽  
Vol 235 (8) ◽  
pp. 2267-2271
Author(s):  
Edward H. Frieden ◽  
Naomi R. Stone ◽  
Noel W. Layman
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document